Home Cart Sign in  
Chemical Structure| 1007647-73-5 Chemical Structure| 1007647-73-5

Structure of Smurf1-IN-A01
CAS No.: 1007647-73-5

Chemical Structure| 1007647-73-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Smurf1-IN-A01 is an inhibitor of negatively regulatory factor Smurf1 for promoting bone formation.

Synonyms: A01; SMURF1 inhibitor A01

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Smurf1-IN-A01

CAS No. :1007647-73-5
Formula : C22H20ClF3N4O3S
M.W : 512.93
SMILES Code : O=C(N1CCN(S(=O)(C2=CC=C(Cl)C(C(F)(F)F)=C2)=O)CC1)C3=CC=C(N4N=CC=C4C)C=C3
Synonyms :
A01; SMURF1 inhibitor A01
MDL No. :MFCD09320899
InChI Key :QFYLTUDRXBNZFQ-UHFFFAOYSA-N
Pubchem ID :17555704

Safety of Smurf1-IN-A01

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
MCF-7 cells 50 nM 24 hours SMURF1 inhibition reduced ERα-positive cell proliferation J Exp Clin Cancer Res. 2018 Feb 12;37(1):24
RAW264.7 cells 10 µM 30 minutes Inhibition of Smurf1 completely blocked Clec2d-mediated degradation of MyD88 Nat Commun. 2023 Oct 23;14(1):6718
T47D cells 50 nM 48 hours SMURF1 inhibition reduced ERα protein levels and target gene expression J Exp Clin Cancer Res. 2018 Feb 12;37(1):24
Rat osteoblasts-like cells ROS17/2.8 2 µM 48 hours Evaluate ALP activity, results showed A01 and A17 significantly increased ALP activity under BMP-2 stimulation Sci Rep. 2014 May 14;4:4965
Mouse pre-osteoblasts MC3T3-E1 2 µM 48 hours Evaluate ALP activity, results showed A01 and A17 significantly increased ALP activity under BMP-2 stimulation Sci Rep. 2014 May 14;4:4965
Mouse myoblasts C2C12 2 µM 48 hours Evaluate ALP activity, results showed A01 and A17 significantly increased ALP activity under BMP-2 stimulation Sci Rep. 2014 May 14;4:4965

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.95mL

0.39mL

0.19mL

9.75mL

1.95mL

0.97mL

19.50mL

3.90mL

1.95mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories